Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Kiniksa Pharmaceuticals (KNSA)

  • Event
  • Aug. 03, 2022, 11:35 UTC
  • 21
  • 1 comments

(10% Negative) Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q3 2022 Financial Results

Comment Full text

Seres Therapeutics Inc (MCRB)

  • Event
  • Aug. 03, 2022, 11:15 UTC
  • 21
  • 1 comments

(30% Negative) SERES THERAPEUTICS, INC. (MCRB) Reports Q3 2022 Financial Results

Comment Full text

Aclaris Therapeutics Inc (ACRS)

  • Event
  • Aug. 03, 2022, 11:15 UTC
  • 21
  • 1 comments

(30% Negative) Aclaris Therapeutics, Inc. (ACRS) Reports Q3 2022 Financial Results

Comment Full text

Amarin Corporation Plc (AMRN)

  • Event
  • Aug. 03, 2022, 11:08 UTC
  • 21
  • 1 comments

(30% Negative) AMARIN CORP PLC\UK (AMRN) Reports Q3 2022 Financial Results

Comment Full text

Regeneron Pharmaceuticals Inc (REGN)

  • Event
  • Aug. 03, 2022, 11:08 UTC
  • 21
  • 1 comments

(10% Negative) REGENERON PHARMACEUTICALS, INC. (REGN) Reports Q3 2022 Financial Results

Comment Full text

EyePoint Pharmaceuticals Inc (EYPT)

  • Event
  • Aug. 03, 2022, 11:07 UTC
  • 21
  • 1 comments

(30% Negative) EyePoint Pharmaceuticals, Inc. (EYPT) Reports Q3 2022 Financial Results

Comment Full text

Horizon Therapeutics plc (was acquisited by Amgen (NASDAQ: AMGN)) (HZNP)

  • Event
  • Aug. 03, 2022, 11:06 UTC
  • 21
  • 1 comments

(10% Negative) Horizon Therapeutics Public Ltd Co (HZNP) Reports Q3 2022 Financial Results

Comment Full text

Moderna Inc (MRNA)

  • Event
  • Aug. 03, 2022, 11:04 UTC
  • 21
  • 1 comments

(30% Negative) MODERNA, INC. (MRNA) Reports Q3 2022 Financial Results

Comment Full text

Intercept Pharmaceuticals Inc (was acquisited by Alfasigma (Italy) on 08/11/2023) (ICPT)

  • Event
  • Aug. 03, 2022, 11:00 UTC
  • 21
  • 1 comments

(10% Negative) Intercept Pharmaceuticals, Inc. (ICPT) Reports Q3 2022 Financial Results

Comment Full text

Surface Oncology Inc (was by Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) on 16/06/2023) (SURF)

  • Event
  • Aug. 03, 2022, 10:51 UTC
  • 21
  • 1 comments

(30% Negative) Surface Oncology Inc (was by Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) on 16/06/2023) (SURF) Reports Q3 2022 Financial Results

Comment Full text
  • Previous
  • 536
  • 537
  • 538
  • 539
  • 540
  • Next

Search

News categories

  • Technical Exchange News(12475)
  • Event(6229)
  • SEC News(283028)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(161726)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin